IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018

IGF::OT::IGF 国家骨髓增生异常综合征 (MDS) 自然史研究，中央实验室和生物样本库 (CLB)，任务令 03，2016 年 9 月 1 日至 2018 年 2 月 28 日

• 批准号: 10653677
• 负责人: Pearlie K Burnette
• 金额: $ 22.3万
• 依托单位: H. LEE MOFFITT CANCER CTR & RES INST
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-01 至 2023-12-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10653677
• 关键词: Adult; Age; Biological Assay; Biological Specimen Banks; Clinical; Collection; Communities; Contracts; Data; Data Coordinating Center; Data Set; Dysmyelopoietic Syndromes; Equipment; Equipment and supply inventories; Funding; Knowledge; Laboratories; National Heart, Lung, and Blood Institute; Natural History; Newly Diagnosed; Observational Study; Participant; Protocols documentation; Research; Services; Syndrome; Technical Expertise; Time; Writing; biobank; data repository; data resource; design; electronic data; laboratory facility; member; programs

The objective of the National Myelodysplastic Syndromes Natural History Study Central Laboratory and Biorepository (The National MDS Study CL/B) is to provide the necessary scientific knowledge, technical expertise and laboratory facilities to design, build, and store a quality biospecimen collection. The National MDS Study is a seven year observational study of 2000 adults newly diagnosed with MDS and up to 500 age-matched participants who are not diagnosed with MDS, but who are clinically suspected of having this syndrome. The National MDS Study will be comprised of one Data Coordinating Center (DCC) funded under a separate contract and one CL/B. Overall coordination of the program will be performed by the DCC.

国家骨髓增生异常综合征自然历史研究中心实验室和生物样本库（国家骨髓增生异常综合征研究 CL/B）的目标是提供必要的科学知识、技术专长和实验室设施，以设计、构建和储存优质生物样本。国家 MDS 研究是一项为期七年的观察性研究，研究对象为 2000 名新诊断患有 MDS 的成年人，以及最多 500 名年龄匹配、未诊断出患有 MDS、但临床怀疑患有这种综合征的参与者。国家 MDS 研究将由一个根据单独合同资助的数据协调中心 (DCC) 和一个 CL/B 组成。该计划的总体协调将由 DCC 进行。